Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC is a research paper published in New England Journal of Medicine (2025). On theSindex it has a DataRank of 0.884. It has been cited 44 times, with 44 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.571
From this paper's citation signal
Citation Network Contribution
0.313
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 44 citers.
National Natural Science Foundation of China
Grant: 82373262
NIH HHS
Grant: 2024ZD0519700
National Natural Science Foundation of China
Grant: 82173101
National Natural Science Foundation of China
Grant: 82272789
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Grant: N/A
National Natural Science Foundation of China
Grant: 82241232
MeSH Terms